Who
Joshua Phillips
Director
Company insider
Files Form 4 as: Director, Sera Prognostics.
In numbers
- Trades disclosed
- 63
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $230K
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 19 Jul 2021
- Last trade
- 10 Jul 2026
- Last filed
- 14 Jul 2026
Companies traded
Activity over time
1 Jan 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jul 2026filed 14 Jul 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Code A | —22,426 at $0.00 | filing |
| 10 Jul 2026filed 14 Jul 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Code A | —2,260 at $0.00 | filing |
| 10 Jul 2026filed 14 Jul 2026 | SERA Sera Prognosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —34,494 at $0.00 | filing |
| 10 Jul 2026filed 14 Jul 2026 | SERA Sera Prognosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —34,494 at $0.00 | filing |
| 10 Jul 2026filed 14 Jul 2026 | SERA Sera Prognosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —3,477 at $0.00 | filing |
| 10 Jul 2026filed 14 Jul 2026 | SERA Sera Prognosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —3,477 at $0.00 | filing |
| 10 Jul 2026filed 14 Jul 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Code A | —22,426 at $0.00 | filing |
| 10 Jul 2026filed 14 Jul 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Code A | —2,260 at $0.00 | filing |
| 5 Jun 2025filed 6 Jun 2025 | SERA Sera Prognosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 5 Jun 2025filed 6 Jun 2025 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Code A | —15,596 at $0.00 | filing |
| 14 Jan 2025filed 14 Jan 2025 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $132 at $6.29 | filing |
| 14 Jan 2025filed 14 Jan 2025 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $30K4,827 at $6.29 | filing |
| 14 Jan 2025filed 14 Jan 2025 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $11K1,814 at $6.29 | filing |
| 14 Jan 2025filed 14 Jan 2025 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $17K2,695 at $6.29 | filing |
| 13 Jan 2025filed 14 Jan 2025 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $193 at $6.39 | filing |
| 13 Jan 2025filed 14 Jan 2025 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $40K6,287 at $6.39 | filing |
| 13 Jan 2025filed 14 Jan 2025 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $15K2,415 at $6.39 | filing |
| 13 Jan 2025filed 14 Jan 2025 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $22K3,458 at $6.39 | filing |
| 10 Jan 2025filed 14 Jan 2025 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $142 at $7.18 | filing |
| 10 Jan 2025filed 14 Jan 2025 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $81 at $8.03 | filing |
News
Arrowhead Pharmaceuticals (NASDAQ:ARWR) versus Sera Prognostics (NASDAQ:SERA) Head to Head ReviewSERA · themarketsdaily.com · 18 Oct 2026Insider Selling: Sera Prognostics (NASDAQ:SERA) Insider Sells 8,024 Shares of Company StockSERA · themarketsdaily.com · 13 Oct 2026
0 headlines in the last 90 days name Joshua Phillips; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.